Search Results - "Verzijlbergen, J Fred"

Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study by Privé, Bastiaan M, Peters, Steffie M B, Muselaers, Constantijn H J, van Oort, Inge M, Janssen, Marcel J R, Sedelaar, J P Michiel, Konijnenberg, Mark W, Zámecnik, Patrik, Uijen, Maike J M, Schilham, Melline G M, Eek, Annemarie, Scheenen, Tom W J, Verzijlbergen, J Fred, Gerritsen, Winald R, Mehra, Niven, Kerkmeijer, Linda G W, Smeenk, Robert J, Somford, Diederik M, van Basten, Jean-Paul A, Heskamp, Sandra, Barentsz, Jelle O, Gotthardt, Martin, Witjes, J Alfred, Nagarajah, James

“…[ Lu]Lu-PSMA-617 radioligand therapy ( Lu-PSMA) is a novel treatment for metastatic castration-resistant prostate cancer (mCRPC), which could also be applied…”
Get full text

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial by Privé, Bastiaan M., Janssen, Marcel J. R., van Oort, Inge M., Muselaers, Constantijn H. J., Jonker, Marianne A., van Gemert, Willemijn A., de Groot, Michel, Westdorp, Harm, Mehra, Niven, Verzijlbergen, J. Fred, Scheenen, Tom W. J., Zámecnik, Patrik, Barentsz, Jelle O., Gotthardt, Martin, Noordzij, Walter, Vogel, Wouter V., Bergman, Andries M., van der Poel, Henk G., Vis, André N., Oprea-Lager, Daniela E., Gerritsen, Winald R., Witjes, J. Alfred, Nagarajah, James

“…Abstract Background The BULLSEYE trial is a multicenter, open-label, randomized controlled trial to test the hypothesis if 177 Lu-PSMA is an effective…”
Get full text

Skeletal 18F-PSMA-1007 uptake in prostate cancer patients by Janssen, Jorinde, Noordzij, Walter, Velleman, Ton, de Jong, Igle Jan, Langendijk, Johannes A., Verzijlbergen, J. Fred, Stormezand, Gilles N., Aluwini, Shafak

“…Background/objectives: Accurate and uniform interpretation and reporting of metastatic prostate cancer (PCa) lesions on prostate-specific membrane antigen…”
Get full text

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 by Boellaard, Ronald, Delgado-Bolton, Roberto, Oyen, Wim J. G., Giammarile, Francesco, Tatsch, Klaus, Eschner, Wolfgang, Verzijlbergen, Fred J., Barrington, Sally F., Pike, Lucy C., Weber, Wolfgang A., Stroobants, Sigrid, Delbeke, Dominique, Donohoe, Kevin J., Holbrook, Scott, Graham, Michael M., Testanera, Giorgio, Hoekstra, Otto S., Zijlstra, Josee, Visser, Eric, Hoekstra, Corneline J., Pruim, Jan, Willemsen, Antoon, Arends, Bertjan, Kotzerke, Jörg, Bockisch, Andreas, Beyer, Thomas, Chiti, Arturo, Krause, Bernd J.

“…The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological…”
Get full text

Imaging of an unusual case of a completely unroofed coronary sinus without persistent left superior vena cava by Snijder, Roel J R, Schaap, Jeroen, Verzijlbergen, J Fred, Post, Martijn C

Get full text

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 by Boellaard, Ronald, O’Doherty, Mike J., Weber, Wolfgang A., Mottaghy, Felix M., Lonsdale, Markus N., Stroobants, Sigrid G., Oyen, Wim J. G., Kotzerke, Joerg, Hoekstra, Otto S., Pruim, Jan, Marsden, Paul K., Tatsch, Klaus, Hoekstra, Corneline J., Visser, Eric P., Arends, Bertjan, Verzijlbergen, Fred J., Zijlstra, Josee M., Comans, Emile F. I., Lammertsma, Adriaan A., Paans, Anne M., Willemsen, Antoon T., Beyer, Thomas, Bockisch, Andreas, Schaefer-Prokop, Cornelia, Delbeke, Dominique, Baum, Richard P., Chiti, Arturo, Krause, Bernd J.

“…The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG)…”
Get full text

Myocardial perfusion SPECT identifies patients with left bundle branch block patterns at high risk for future coronary events by ten Cate, Tim J. F., Kelder, Johannes C., Plokker, Herbert W. M., Fred Verzijlbergen, J., van Hemel, Norbert M.

“…Background The value of myocardial perfusion SPECT (MPS) for patients with left bundle branch block (LBBB) or right ventricular apical (RVA) pacing seems…”
Get full text

Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy by Chan, Ho Sze, de Blois, Erik, Konijnenberg, Mark W., Morgenstern, Alfred, Bruchertseifer, Frank, Norenberg, Jeffrey P., Verzijlbergen, Fred J., de Jong, Marion, Breeman, Wouter A. P.

“…Background 213 Bismuth ( 213 Bi, T 1/2 = 45.6 min) is one of the most frequently used α-emitters in cancer research. High specific activity radioligands are…”
Get full text

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline by Staal, Floor H.E., Janssen, Jorinde, Oprea-Lager, Daniela E., Engelen, Antoine M., van Limbergen, Evert J., Smeenk, Robert Jan, de Jong, Marianne A.A., Budiharto, Tom C.G., Jacobs, Inge, Haverkort, Dorien M.A.D., Brouwer, Charlotte L., Ng Wei Siang, Kelvin, Langendijk, Johannes A., Verzijlbergen, J. Fred, de Jong, Ingle Jan, Noordzij, Walter, Aluwini, Shafak

“…Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scan is the standard imaging procedure for biochemical…”
Get full text

Effects of Pacing Rates on Global and Regional Myocardial Blood Flow by Ten CATE, TIM J.F., KNAAPEN, PAUL, LAMMERTSMA, ADRIAAN A., De COCK, CAREL C., Van HEMEL, NORBERT M., VERZIJLBERGEN, J. FRED

“…Background:  Information is scarce on the effects of right ventricular apical (RVA) pacing on regional and global myocardial blood flow (MBF). The purpose of…”
Get full text

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial by Privé, Bastiaan M, Janssen, Marcel J R, van Oort, Inge M, Muselaers, Constantijn H J, Jonker, Marianne A, de Groot, Michel, Mehra, Niven, Verzijlbergen, J Fred, Scheenen, Tom W J, Zámecnik, Patrik, Barentsz, Jelle O, Gotthardt, Martin, Noordzij, Walter, Vogel, Wouter V, Bergman, Andries M, van der Poel, Henk G, Vis, André N, Oprea-Lager, Daniela E, Gerritsen, Winald R, Witjes, J Alfred, Nagarajah, James

“…In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with…”
Get full text

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials by Boellaard, Ronald, Oyen, Wim J. G., Hoekstra, Corneline J., Hoekstra, Otto S., Visser, Eric P., Willemsen, Antoon T., Arends, Bertjan, Verzijlbergen, Fred J., Zijlstra, Josee, Paans, Anne M., Comans, Emile F. I., Pruim, Jan

“…Introduction Several studies have shown the usefulness of positron emission tomography (PET) quantification using standardised uptake values (SUV) for…”
Get full text

GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients by Bakker, Ingrid L, Fröberg, Alida C, Busstra, Martijn B, Verzijlbergen, J Fred, Konijnenberg, Mark, van Leenders, Geert JLH, Schoots, Ivo G, de Blois, Erik, van Weerden, Wytske M, Dalm, Simone U, Maina, Theodosia, Nock, Berthold A, de Jong, Marion

“…The gastrin-releasing peptide receptor (GRPr) is overexpressed in prostate cancer (PCa) cells, making it an excellent tool for targeted imaging. The…”
Get full text

GRPr Antagonist 68 Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients by Bakker, Ingrid L, Fröberg, Alida C, Busstra, Martijn B, Verzijlbergen, J Fred, Konijnenberg, Mark, van Leenders, Geert J L H, Schoots, Ivo G, de Blois, Erik, van Weerden, Wytske M, Dalm, Simone U, Maina, Theodosia, Nock, Berthold A, de Jong, Marion

“…The gastrin-releasing peptide receptor (GRPr) is overexpressed in prostate cancer (PCa) cells, making it an excellent tool for targeted imaging. The Ga-labeled…”
Get full text

Skeletal 18 F-PSMA-1007 uptake in prostate cancer patients by Janssen, Jorinde, Noordzij, Walter, Velleman, Ton, de Jong, Igle Jan, Langendijk, Johannes A, Verzijlbergen, J Fred, Stormezand, Gilles N, Aluwini, Shafak

“…Accurate and uniform interpretation and reporting of metastatic prostate cancer (PCa) lesions on prostate-specific membrane antigen (PSMA) positron emission…”
Get full text

18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis by Keijsers, Ruth G., Verzijlbergen, Fred J., Oyen, Wim J., van den Bosch, Jules M., Ruven, Henk J., van Velzen-Blad, Heleen, Grutters, Jan C.

“…Purpose Angiotensin-converting enzyme (ACE) and soluble interleukin-2 receptor (sIL-2R) are serological markers, widely used for determining sarcoidosis…”
Get full text

Skeletal F-PSMA-1007 uptake in prostate cancer patients by Jorinde Janssen, Walter Noordzij, Ton Velleman, Igle Jan de Jong, Johannes A. Langendijk, J. Fred Verzijlbergen, Gilles N. Stormezand, Shafak Aluwini

“…Background/objectives: Accurate and uniform interpretation and reporting of metastatic prostate cancer (PCa) lesions on prostate-specific membrane antigen…”
Get full text

18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice by Swart, Laurens E, Scholtens, Asbjørn M, Tanis, Wilco, Nieman, Koen, Bogers, Ad J J C, Verzijlbergen, Fred J, Krestin, Gabriel P, Roos-Hesselink, Jolien W, Budde, Ricardo P J

“…Abstract The timely diagnosis of prosthetic heart valve endocarditis remains challenging yet of utmost importance. 18F-fluorodeoxyglucose (18 F-FDG) positron…”
Get full text

Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions by Schaap, Jeroen, de Groot, Joris A H, Nieman, Koen, Meijboom, W Bob, Boekholdt, S Matthijs, Post, Martijn C, Van der Heyden, Jan A S, de Kroon, Thom L, Rensing, Benno J W M, Moons, Karel G M, Verzijlbergen, J Fred

“…To evaluate to what extent treatment decisions for patients with stable angina pectoris can be made based on hybrid myocardial perfusion single-photon emission…”
Get more information

Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial by Staal, Floor H.E., Siang, Kelvin Ng Wei, Brouwer, Charlotte L., Janssen, Jorinde, Budiharto, Tom C.G., Haverkort, Dorien M.A.D., Hollmann, Birgit, Jacobs, Inge, De Jong, Marianne A.A., van de Sande, Mariska A.E., Vanneste, Ben G.L., De Jong, Igle Jan, Verzijlbergen, J. Fred, Langendijk, Johannes A., Smeenk, Robert Jan, Aluwini, Shafak

“…The PERYTON trial is a multicenter randomized controlled trial that will investigate whether the treatment outcome of salvage external beam radiation therapy…”
Get full text